Clinical Efficacy and Mechanism of Shensong Yangxin Capsules in the Treatment of Ventricular Arrhythmias after Myocardial Infarction: Rationale and Design

Huang He,Huang Congxin,Tang Yanhong,Wang Xi,Liu Yu,Kong Bin,Hu Dan,Xiong Liang,Shen Caijie,Shuai Wei
DOI: https://doi.org/10.3760/cma.j.issn.1007-6638.2018.03.005
2018-01-01
Abstract:Background Ventricular arrhythmias occur frequently in patients after myocardial infarction,which can decrease quality of life,worsen cardiac function and increase the risk of mortality. However,effective and safe antiarrhythmic drugs are limited. Rationale The mechanism underlying ventricular arrhythmias after myocardial infarction involves structural,electrical and neural remodeling. Shensong Yangxin capsules (SSYX) is now well known with the effects of modulatory of multiple ion current, cardiac remodeling,and autonomic nervous function. Previous studies suggested that SSYX was effective and safe for the treatment of ventricular arrhythmias. Design "Clinical efficacy and mechanism of SSYX in the treatment of ventricular arrhythmias after myocardial infarction" study includes two parts. ①Clinical study of SSYX in the treatment of ventricular arrhythmias after myocardial infarction. The primary endpoint is reduction of arrhythmia burden by Holter monitoring. The secondary endpoints include the improvement of arrhythmia symptoms,quality of life and cardiac function,etc. ②Effects and mechanism of SSYX on ventricular arrhythmia in ischemia-reperfusion rabbit heart. Conclusion "Clinical efficacy and mechanism of SSYX in the treatment of ventricular arrhythmias after myocardial infarction" study will clarify the clinical efficacy and safety of SSYX in the treatment of ventricular arrhythmias after myocardial infarction,illustrate the underling mechanism,and eventually provide scientific evidence for the treatment of ventricular arrhythmias after myocardial infarction.
What problem does this paper attempt to address?